We also found that GPR50 knockdown attenuates cell proliferation, sphere formation, migration, and drug resistance of HCC cells, whereas overexpression of GPR50 upregulates cancer properties in hepatocytes (see Figures 2 and 7), strongly supporting an oncogenic function for GPR50 in HCCs. The gene discussed is GPR50; the disease is hepatocellular carcinoma.